Testing effectiveness (Phase 2)WithdrawnNCT07172867
What this trial is testing
A Ph2 Study to Evaluate the Safety, Efficacy and Tolerability of HT-6184 and Semaglutide in Obese Participants With T2DM
Who this might be right for
Diabetes Mellitus, Type 2Obesity
Halia Therapeutics, Inc.